Genedx Holdings Corp | Mid-cap | Healthcare
$89.79
-0.55%
| Genedx Holdings Stock Comparison:
Genedx Holdings vs Thermo FisherGenedx Holdings vs DanaherGenedx Holdings vs Qiagen N.VGenedx Holdings vs Medpace HoldingsGenedx Holdings vs Charles RiverGenedx Holdings vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 305.4M
Gross Profit 194.4M 63.64%
Operating Income -23.2M -7.60%
Net Income -52.3M -17.12%

Balance Sheet Metrics

Total Assets 419.4M
Total Liabilities 174.1M
Shareholders Equity 245.2M
Debt to Equity 0.71

Cash Flow Metrics

Operating Cash Flow -21.6M
Free Cash Flow -34.0M

Revenue & Profitability Trend

Genedx Holdings Income Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Revenue 305.4M 202.6M 234.7M 212.2M 179.3M
Cost of Goods Sold 111.1M 112.6M 261.4M 228.8M 175.3M
Gross Profit 194.4M 90.0M -26.8M -16.6M 4.0M
Operating Expenses 217.6M 260.2M 430.8M 429.5M 246.0M
Operating Income -23.2M -170.2M -457.5M -446.1M -242.0M
Pre-tax Income -52.6M -176.7M -598.0M -245.4M -241.3M
Income Tax -343.0K -926.0K -49.1M 0 0
Net Income -52.3M -175.8M -549.0M -245.4M -241.3M
EPS (Diluted) - -$7.23 -$53.79 -$74.91 -$33.16

Income Statement Trend

Genedx Holdings Balance Sheet From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Assets
Current Assets 198.0M 182.3M 212.6M 483.5M 174.1M
Non-Current Assets 221.4M 236.4M 278.3M 70.5M 77.5M
Total Assets 419.4M 418.8M 490.9M 554.1M 251.6M
Liabilities
Current Liabilities 54.8M 58.8M 144.3M 101.3M 73.4M
Non-Current Liabilities 119.3M 131.9M 92.9M 64.7M 508.3M
Total Liabilities 174.1M 190.7M 237.2M 166.0M 581.7M
Equity
Total Shareholders Equity 245.2M 228.0M 253.7M 388.1M -330.1M

Balance Sheet Composition

Genedx Holdings Cash Flow Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Operating Activities
Net Income -52.3M -175.8M -549.0M -245.4M -241.3M
Operating Cash Flow -21.6M -141.9M -514.1M -6.1M -110.4M
Investing Activities
Capital Expenditures -5.5M -5.2M -7.2M -9.4M -24.1M
Investing Cash Flow -30.1M -55.4M -134.2M -9.4M -24.1M
Financing Activities
Dividends Paid - - - - -
Financing Cash Flow 43.3M 186.0M 392.0M 492.5M 129.1M
Free Cash Flow -34.0M -185.9M -333.5M -211.2M -125.1M

Cash Flow Trend

Genedx Holdings Key Financial Ratios

Valuation Ratios

Forward P/E 185.51
Price to Book 10.08
Price to Sales 7.86
PEG Ratio 185.51

Profitability Ratios

Profit Margin -11.69%
Operating Margin -5.22%
Return on Equity -16.61%
Return on Assets -1.84%

Financial Health

Current Ratio 3.25
Debt to Equity 44.61
Beta 2.01

Per Share Data

EPS (TTM) -$1.39
Book Value per Share $9.02
Revenue per Share $12.04

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
wgs 2.6B - 10.08 -16.61% -11.69% 44.61
Thermo Fisher 152.5B 23.69 3.09 13.70% 15.19% 69.23
Danaher 140.5B 37.98 2.76 7.22% 15.81% 34.56
Qiagen N.V 10.1B 108.63 2.97 2.67% 4.68% 41.36
Medpace Holdings 8.9B 23.58 15.48 65.83% 19.31% 25.33
Charles River 7.2B 681.33 2.27 -0.67% -0.49% 92.21

Financial data is updated regularly. All figures are in the company's reporting currency.